品牌:深圳远扬生物
起订:10mg
供应:1000mg
发货:5天内
信息标签:托法替尼杂质 现货库存,供应,化工,化学试剂
点击这里进行电话呼叫
点击这里QQ咨询
联系时一定要说在【贸易商务资源网】看到的将给您优惠！如果您也想和该公司一样在网站发信息有好排名，点击立即免费注册，发布产品推广。
托法替尼杂质 现货库存
发布时间:2017-10-30 17:05:06 产品编号:GY-5-173093903 分享
价格:0.00/mg
品牌:深圳远扬生物
起订:10mg
供应:1000mg
发货:5天内
信息标签:托法替尼杂质 现货库存,供应,化工,化学试剂
品牌:深圳远扬生物
起订:10mg
供应:1000mg
发货:5天内
信息标签:托法替尼杂质 现货库存,供应,化工,化学试剂
托法替尼杂质 现货库存
深圳远扬生物技术有限公司可提供托法替尼申报所用全套杂质， 随货附CoA证书，HNMR，MS，HPLC图谱，纯度符合申报要求，欢迎联系我司获取具体结构式。
何经理：15012456311；phastandards@gmail.com；QQ：277716420
托法替尼杂质国产及进口均有销售，国产备有现货，货期短，并可接受定制。
托法替尼杂质 现货库存
深圳远扬生物技术有限公司可提供托法替尼申报所用全套杂质， 随货附CoA证书，HNMR，MS，HPLC图谱，纯度符合申报要求，欢迎联系我司获取具体结构式。
何经理：15012456311；phastandards@gmail.com；QQ：277716420
托法替尼杂质国产及进口均有销售，国产备有现货，货期短，并可接受定制。
托法替尼杂质 现货库存
|
Tofacitinib |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
C16H20N6O |
312.37 |
|
Tofacitinib Impurity 1 |
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-1H-indol-4-amine |
C22H27N3 |
333.47 |
|
Tofacitinib Impurity 2 |
2-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
C13H18ClN5 |
279.77 |
|
Tofacitinib Impurity 3 |
3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile |
C16H19ClN6O |
346.81 |
|
Tofacitinib Impurity 4 |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
C16H20N6O |
312.37 |
|
Tofacitinib Impurity 5 |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide |
C16H22N6O2 |
330.38 |
|
Tofacitinib Impurity 6 |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoic acid |
C16H21N5O3 |
331.37 |
|
Tofacitinib Impurity 7 |
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
C20H24ClN5 |
369.89 |
|
Tofacitinib Impurity 8 |
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride |
C13H19N5·HCl |
281.78 |
|
Tofacitinib Impurity 9 |
3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile compound with 3-((3S,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (1:1) |
C16H20N6O |
312.37 |
|
Tofacitinib Impurity 10 |
3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
C16H20N6O |
312.37 |
|
Tofacitinib Impurity 11 |
(3R,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
C14H22N2·2HCl |
291.26 |
|
Tofacitinib Impurity 12 |
(3S,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
C14H22N2·2HCl |
291.26 |
|
Tofacitinib Impurity 13 |
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
C14H22N2·2HCl |
291.26 |
|
Tofacitinib Impurity 14 |
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
C14H22N2·2HCl |
291.26 |
|
Tofacitinib Impurity 15 |
3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile |
C22H23N9O |
429.48 |
|
Tofacitinib Impurity 16 |
(3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carbaldehyde |
C14H19N5O |
273.33 |
|
Tofacitinib Impurity 17 |
N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
C19H22N8 |
362.43 |
|
Tofacitinib Impurity 18 |
3,3'-((3R,3'R,4R,4'R)-3,3'-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis(methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxopropanenitrile) |
C26H35N9O2 |
505.62 |
|
Tofacitinib Impurity 19 |
3-(4-(((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)(methyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-oxopropanenitrile |
C19H21N7O2 |
379.42 |
|
Tofacitinib Impurity 20 |
3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile |
C16H22N6O |
314.39 |
|
Tofacitinib Impurity 21 |
N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide |
C16H20N6O2 |
328.37 |
|
Tofacitinib Impurity 22 |
(3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine hydrochloride |
C13H18ClN5·HCl |
316.23 |
|
Tofacitinib Impurity 23 |
(3R,4R)-N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine |
C13H19N5 |
245.32 |
|
Tofacitinib Impurity 24 |
N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride |
C14H21N5 |
295.81 |
|
Tofacitinib Impurity 25 |
1-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone |
C15H21N5O |
287.36 |
|
Tofacitinib Impurity 26 |
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine compound with N-((3S,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (1:1) |
C27H31N5O2S |
489.63 |
|
Tofacitinib Impurity 27 |
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
C27H31N5O2S |
489.63 |
托法替尼杂质 现货库存
深圳远扬化学技术有限公司可现货供应各种杂质对照品，医药标准品：西格列汀杂质，维格列汀杂质，匹伐他汀杂质，依鲁替尼杂质，利伐沙班杂质，伊伐布雷定杂质，托匹司他杂质，奥贝胆酸杂质，奥美拉唑杂质，卡格列净杂质，曲氟脲苷杂质，阿加曲班杂质，利格列汀杂质，瑞舒伐他汀杂质，奥美沙坦酯杂质，托法替尼杂质等，图谱证书齐全，纯度保证。
联系方式
公司:深圳远扬生物技术有限公司
状态:离线 发送信件
姓名:何德华(先生)
电话:0755-89554301
手机:15012456311
传真:0755-89554301
地区:广东-深圳市
地址:深圳市龙岗区龙平东路郭尾新村11号604室
QQ:781007885
商铺:http://m.ceoie.com/781007885/
状态:离线 发送信件
姓名:何德华(先生)
电话:0755-89554301
手机:15012456311
传真:0755-89554301
地区:广东-深圳市
地址:深圳市龙岗区龙平东路郭尾新村11号604室
QQ:781007885
商铺:http://m.ceoie.com/781007885/
去深圳远扬生物技术有限公司怎么走？上图中的红点是深圳远扬生物技术有限公司在深圳市的具体位置标注，操作左上角地图工具可以放大缩小哦。
相关信息
[化学试剂] 推荐供应
最新发布信息
点击分享到微信、朋友圈、QQ...